Company intelligence / Profile preview

Advanced Plasma Products

Lenoir City, Tennessee, United States

Ownership: Private
Development stage: Other

Overview

Developing APWA device for chronic wound treatment; completed SBIR Phase II grant with in vivo animal model testing planned, focusing on disinfection of biofilm infections and wound healing.

Therapeutic areas: CardiovascularDermatologyInfectious Diseases
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

University of Tennessee Health Science Center College of Medicine – Knoxville, Graduate School of Medicine (UTHSCCOM-GSM)Center for Biofilm Engineering at Montana State UniversityCollege of Veterinary Medicine of The University of Tennessee

Beyond the preview

Go deeper on Advanced Plasma Products.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advanced Plasma Products.

Explore the full profile